Background: Sickle cell disease (SCD) includes a group of inherited red blood cell disorders. SCD patients vary widely from person to person. We describe β S and β C haplotypes and α-thalassemia 3.7 kb genotypes from SCD patients Fundacao Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, AM.
Introduction
Sickle cell disease (SCD) is a severe genetic disorder that affects populations around the world and is characterized by the presence of hemoglobin S (HbS) inside the erythrocyte. The condition is caused by a point mutation GAG>GTG on the sixth position of the β-globin gene, resulting in the replacement of glutamic acid by valine in the polypeptide beta chain (β S ) [1] . A variation GAG>AAG in the same locus induces a change from glutamic acid to lysine that characterizes the β C chain. Homozygosis for β S results in a disorder known as sickle cell anemia (HbSS); individual's heterozygous β S β C presents hemoglobin SC (HbSC) disease [2, 3] .
HbSS patients present atypical red blood cells (RBCs) with classic sickle-shape that do not circulate properly in the microcirculation, causing blood flow obstruction, hemolysis and vaso-occlusive crisis (VOC) [4] . These events are responsible for the main clinical manifestations of the disease, as well as for significant morbidity and reduction of life expectancy [5] . HbSC patients present target-shape RBC and manifest similar clinical features of those with HbSS, however, in a lower frequency and intensity [6, 7] .
Hematologic and biochemical parameters, as well as clinical manifestation of both HbSS and HbSC diseases, are influenced by genetic factors such as haplotypes of the β-globin gene cluster and the α-thalassemia 3.7 kb deletion [8] [9] [10] [11] . Different haplotypes linked to the β S globin gene have been described in SCD patients from Senegal (Sen), Benin (Ben), Central African Republic (CAR), Cameroon (Cam) and Arab-Indian (Arab) and have been named according to the geographical region or ethnic group in which they have been originally identified. Among HbSC patients, haplotype groups have been characterized as Sen/I, Sen/II, Sen/III, Ben/I, Ben/II, Ben/III, Car/I, Car/II, and Car/III [8, 9, 12] .
The presence of α-thalassemia in patients with SCD is associated to milder phenotypes, as the polymerization potential of HbS and HbC decreases, leading to the presence of fewer dense cells with little deforming and increased hematocrit, reducing the vaso-occlusive events and preserving spleen function [6, 9, 13] .
Although molecular characterization surveys of popula- [14] [15] [16] [17] [18] [19] . In addition, for some particularly interesting regions of Brazil, such as the occidental Amazon, this molecular profile is still widely unknown. Finally, few studies have compared biochemical and hematological parameters across SCD individuals of different β-globin and α-thalassemia molecular backgrounds. Here we describe the β-globin and α-thalassemia genetic profile of a population sample of individuals affected by sickle cell and hemoglobin SC disease from the Brazilian Amazon, presented and discussed in the context of a comprehensive hematological and biochemical profile [20] [21] [22] [23] .
Materials and Methods
The studied population sample was composed by 150 SCD patients attending the Peripheral blood samples for the hematological and biochemical analysis were obtained during a routine appointment for follow-up. The hematological analysis was performed using the automated hematologic analyzer BC-5800 (Mindray, Shenzhe, China); data were obtained for the overall count of RBCs, concentration of hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red blood cell distribution width (RDW), total and differential leukocyte count and platelet count. Fetal hemoglobin (HbF) Carneiro et al J Hematol. 2016;5(4):123-128 detection was performed using the alkaline resistance biochemical test [24] . Biochemical parameters were measured as implemented in the automated A25 platform (BioSystems SA, Barcelona, Spain) and included serum concentration of urea, creatinine, direct and indirect bilirubin, glucose, triglycerides, iron and ferritin, as well as gamma-glutamyl transferase (GGT) and lactate dehydrogenase activity (LDH). Genomic DNA was obtained from peripheral blood using HiYield Genomic DNA extraction kit (BioAmerica Inc., USA). NanoDrop ND-1000 (Isogen Life Science, the Netherlands) was used to measure DNA concentration. Seven specific loci of the β-globin gene located in the short arm of chromosome 11 were amplified and genotyped by PCR-RFLP, as described previously [25] . In brief, the amplified fragments were digested by the following restriction enzymes: Xmn I (position 5' of the γ G ), Hinc II (pseudogene ψβ), Hinf I and Hpa I (of regions 5' and 3' of the β-gene, respectively). After digestion, DNA fragments were separated by electrophoresis in agarose gel in 1% under a constant 80 V for 45 min and visualized under ultraviolet light.
Genotyping of the α-thalassemia 3.7 kb deletion was performed by ASO-PCR as described by Baysal and Huisman, using the proposed nomenclature for normal (A + C) or mutated (A + B) genotypic profiles. The PCR products were submitted to electrophoresis (Bio-Rad, EUA) in agarose gel in 1% under a constant 80 V for 45 min and visualized under ultraviolet light. Patients were distributed into three groups: normal (A + C), heterozygous (A + C) + (A + B) and homozygous (A + B) for the deletion [26] .
Statistical analyzes were performed using one-way ANO-VA and Kruskal-Wallis test, as implemented in SPSS, version 22.0. P-values < 0.05 were considered significant. Table 1 summarizes and compares the hematological and biochemical parameters across the two sub-population samples of HbSS and HbSC individuals. As expected, statistically significant differences were observed for all hematological parameters except reticulocyte count. Biochemical parameters including creatinine, indirect bilirubin, lactate dehydrogenase (LDH) cholesterol and LDH activity were also different across HbSS and HbSC.
Results
The CAR/CAR haplotype was the most frequent in HbSS individuals (73, 52.5%), followed by CAR/Benin (33, 23.7%), Benin/Benin (25, 18%), CAR/Senegal (4, 2.9%), Benin/Senegal (2, 1.4%), and CAR/Cameroon (2, 1.4%). Among the HbSC individuals, the haplotype distribution was CAR/CI (4, 36.3%), Benin/CI (3, 27.3%), CAR/CII (2, 18.2%), CAR/CIII (1, 9.1%), and Benin/CII (1, 9.1%). Due to the small number of HbSC individuals, the distribution of hematological and biochemical parameters was analyzed only for the HbSS sub-sample (Table 2) . When comparing the hematological data among the most frequent haplotypes found in our study, only the MCV presented statistical significance, and the CAR/Ben haplotype presented higher concentration (Fig. 1) .
A clear, statistically significant difference was observed for the HbF distribution, with heterozygous CAR/Ben and CAR/Sen presenting average levels of HbF twice and four times as higher that CAR/CAR, respectively. In addition, it is interesting to note that the leucocyte count is reduced among the four individuals CAR/Senegal. Finally, borderline significant differences were detected for RBC count, hematocrit and platelet count.
The single biochemical parameter that showed differential distribution across the haplotype groups was direct bilirubin that was significantly lower (P = 0.029) in the CAR/Cameroon group (0.45 ± 0.07) as compared to CAR/CAR (0.88 ± 0.35), CAR/Ben (0.82 ± 0.38), CAR/Sen (0.70 ± 0.21), Ben/Ben (1.17 ± 0.68) and Ben/Sen (0.78 ± 0.59).
The α-thalassemia 3.7 kb deletion was detected at a frequency of 16.5% in the HbSS group. Of these, 13.7% (19) were heterozygote's (-α/α) and 2.8% (4) were homozygote's (-α/-α). Table 3 summarizes the distribution of hematological parameters across two groups of HbSS patients presenting (carriers, both homo-and heterozygous) or not (wild type) the α-thalassemia 3.7 kb deletion. None of the patients SC presented the α-thalassemia 3.7 kb deletion. Statistically significant differences between the two groups were observed for RBC count, hemoglobin, hematocrit, MCV and MCH.
Discussion
The hematologic correlations between HbSS and HbSC patients included in this survey (Table 1) showed a classic profile of laboratory findings associated to sickle cell anemia and SCD. In HbSS patients, there is severe normocytic normochromic anemia associated with reticulocytosis and leukocytosis; HbSC patients presented much milder hematological changes, if any. Of note, LDH activity was above the reference interval on both groups and significantly higher in HbSS patients, suggesting intense hemolysis. Parameters such as MCV, MCH and RDW were higher in HbSS patients, corroborating surveys such as performed by Colella et al in patients with SCD attended in Hematologic and Center of Hematology and Hemotherapy (Sao Paulo, Brazil). In addition, a more pronounced leukocytosis among HbSS patients confirms the participation of leukocytes in the pathophysiology of the disease, likely due to the participation in vaso-occlusive events and not necessarily in infectious processes [27] . Several haplotypes distribution analyses of variants linked to the globin β S gene have been published using population samples from distinct Brazilian regions, with conflicting results. Most of these studies show a predominance of CAR as compared to Ben (the two most frequent genotypes the same result observed here [16, 20, 23, 28] . However, studies performed in population samples from northern Brazilian cities of Salvador and Fortaleza resulted in a predominance of Ben over CAR [12, 19, 21, 29, 30] . Two previous surveys have been published using population samples of β S individuals resident in the Brazilian Amazonic region. The first was performed using a population sample from Belem, capital city of Para, with results somewhat distinct from the present study: three major African haplotypes (CAR, Benin and Senegal) have been identified among 30 SCD patients, with frequencies as follows: CAR/ CAR 43%, CAR/Benin 47%, Ben/Ben 7% and Sen/Sen 3%. Sixty-seven percent of the β S chromosomes analyzed were of the CAR type, 30% of the Benin and 3% Senegal [17] . The second focused on African descendants with SCD from three small communities from the Brazilian northern states of Para and Amapa (Curiau, Pacoval and Trombetas) and revealed an even more pronounced predominance of the CAR genotype (60%) as compared to Sen (30%) and Ben (10%) [17, 18] . These discrepancies observed across Brazilian studies involving population samples from different -and even the same -geographic region may be explained by differences in study design (mainly sample sizes) and patterns of migration of Africans to Brazil during the slavery period, and reinforce the need for local surveys.
Results of the comparative analysis of hematological and biochemical parameters across haplotype groups reveal an expected protection of the Benin and Senegal genotypes as compared to CAR, mainly due to a correlation with the levels of HbF, significantly higher in Ben/Sen haplotypes (Table 2) [9, 31, 32] . Interestingly, heterozygous CAR/Ben and CAR/Sen present average levels of HbF twice and four times as higher that CAR/CAR, respectively, suggesting a direct relationship between these variables. Importantly, this must be interpreted with caution due to the small number of CAR/Sen individuals in our sample.
Coexistence of the α-thalassemia 3.7 kb deletion with SCD promotes increase of the erythrocyte's membrane/cytoplasm ratio with reduced electrolyte loss and cellular dehydration, reduced hemolysis, increase in the concentration of hemoglobin and hematocrit, decreased erythrocyte indices (MCV and MCH) and the reticulocyte count, as shown in our sample [33, 34] . The frequency of the 3.7 kb deletion of our sample of HbSS individuals does not differ from previous Brazilian studies [30, 35] . Our results confirm Rumaney et al that observed an increase in the amounts of RBCs and hemoglobin and reduced MCV in SCD patients also harboring the α-thalassemia 3.7 kb deletion [36] . Pandey et al showed an increase in all parameters (erythrocytes, hemoglobin, hematocrit, MCV and MCH) in HbSS patients with α-thalassemia [37] .
In summary, our results show the distribution of β S and β C haplotypes and of α-thalassemia 3.7 kb deletion in a large population sample of SCD patients from the Occidental Brazilian Amazon and the impact of these genotypes over hematological and biochemical parameters, contributing to the expansion of knowledge about the molecular characterization of these diseases in Brazilian populations.
